Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-31

Clinical Trial Update: Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is planned to compare the efficacy and safety of GLARGEN® (insulin glargine) versus NPH insulin in Tunisian adults with diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLARGEN® (insulin glargine)
  • NPH insulin (insulin isophane)

Snippet

Sponsor: Les Laboratoires des Médicaments Stériles | Conditions: Diabetes Mellitus | Phase 4 | Status: NOT_YET_RECRUITING